Literature DB >> 8718966

Alginate polycation microcapsules. II. Some functional properties.

B Thu1, P Bruheim, T Espevik, O Smidsrød, P Soon-Shiong, G Skjåk-Braek.   

Abstract

The main cause of alginate polycation capsule breakage under physiological conditions is probably the osmotic swelling of the alginate core owing to the Donnan equilibrium set up by the negative charges of the carboxyl groups not involved in cooperative binding of counterions in the junction zones of the network. In the present paper we show how capsules can be stabilized extensively by reducing their swelling capacity in various ways. Alginate polycation capsules with good chemical and mechanical stability have been made by controlling their swelling behaviour through selection of capsule material according to chemical structure and molecular weight, as well as by controlling the kinetics of the capsule formation. Stable capsules have been made either by increasing the strength of the polyanion-polycation membrane, or by keeping a low-swelling gel network in the core. The latter capsules are made from an alginate rich in guluronic acid both in the core and in an outer coating, and with anisotropic distribution of the polymer material in the core where the concentration at the surface is higher than that in the centre of the capsule. Some functional properties of these capsules, such as porosity, have also been studied.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8718966     DOI: 10.1016/0142-9612(96)85907-2

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  36 in total

1.  Chemoselective cross-linking and functionalization of alginate via Staudinger ligation.

Authors:  Kerim M Gattás-Asfura; Cherie L Stabler
Journal:  Biomacromolecules       Date:  2009-11-09       Impact factor: 6.988

Review 2.  Biocompatibility issues of implantable drug delivery systems.

Authors:  H Park; K Park
Journal:  Pharm Res       Date:  1996-12       Impact factor: 4.200

3.  Protective antibody response following oral vaccination with microencapsulated Bacillus Anthracis Sterne strain 34F2 spores.

Authors:  Jamie Benn Felix; Sankar P Chaki; Yi Xu; Thomas A Ficht; Allison C Rice-Ficht; Walter E Cook
Journal:  NPJ Vaccines       Date:  2020-07-10       Impact factor: 7.344

Review 4.  Stem cell microencapsulation for phenotypic control, bioprocessing, and transplantation.

Authors:  Jenna L Wilson; Todd C McDevitt
Journal:  Biotechnol Bioeng       Date:  2013-01-17       Impact factor: 4.530

5.  Quantitative Tissue Spectroscopy of Near Infrared Fluorescent Nanosensor Implants.

Authors:  Nicole M Iverson; Gili Bisker; Edgardo Farias; Vsevolod Ivanov; Jiyoung Ahn; Gerald N Wogan; Michael S Strano
Journal:  J Biomed Nanotechnol       Date:  2016-05       Impact factor: 4.099

6.  Microencapsulation of small intestinal neuroendocrine neoplasm cells for tumor model studies.

Authors:  Anne M Rokstad; Björn I Gustafsson; Terje Espevik; Ingunn Bakke; Roswitha Pfragner; Bernhard Svejda; Irvin M Modlin; Mark Kidd
Journal:  Cancer Sci       Date:  2012-04-27       Impact factor: 6.716

7.  Microencapsulating and Banking Living Cells for Cell-Based Medicine.

Authors:  Wujie Zhang; Xiaoming He
Journal:  J Healthc Eng       Date:  2011-12       Impact factor: 2.682

8.  Biocompatibility and immune acceptance of adult porcine islets transplanted intraperitoneally in diabetic NOD mice in calcium alginate poly-L-lysine microcapsules versus barium alginate microcapsules without poly-L-lysine.

Authors:  Susan A Safley; Hong Cui; Sean Cauffiel; Carol Tucker-Burden; Collin J Weber
Journal:  J Diabetes Sci Technol       Date:  2008-09

Review 9.  Immunoisolation: where regenerative medicine meets solid organ transplantation.

Authors:  Rajesh Pareta; Brian Sanders; Paurush Babbar; Tom Soker; Christopher Booth; John McQuilling; Sittadjody Sivanandane; Robert J Stratta; Giuseppe Orlando; Emmanuel C Opara
Journal:  Expert Rev Clin Immunol       Date:  2012-09       Impact factor: 4.473

10.  Human beta-cell precursors mature into functional insulin-producing cells in an immunoisolation device: implications for diabetes cell therapies.

Authors:  Seung-Hee Lee; Ergeng Hao; Alexei Y Savinov; Ifat Geron; Alex Y Strongin; Pamela Itkin-Ansari
Journal:  Transplantation       Date:  2009-04-15       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.